Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 2 1

Status

Completed 2Recruiting 1Not yet recruiting 1Active not recruiting 1

Sponsor Class

OTHER 4INDUSTRY 1

Study Type

Observational 3Interventional 2

Sponsor

Cancer Type

Genitourinary 5

Conditions

Breast Neoplasms 13138Neoplasms 10481Carcinoma, Non-Small-Cell Lung 6874Prostatic Neoplasms 6268Colorectal Neoplasms 5948Lung Neoplasms 5105Multiple Myeloma 3577Pancreatic Neoplasms 3563Leukemia, Myeloid, Acute 3510Neoplasm Metastasis 3508Carcinoma, Hepatocellular 3273Ovarian Neoplasms 3168Melanoma 3141Stomach Neoplasms 3057Lymphoma 2983Head and Neck Neoplasms 2604Recurrence 2557Precursor Cell Lymphoblastic Leukemia-Lymphoma 2499Leukemia 2362Colonic Neoplasms 2328Brain Neoplasms 2313Lymphoma, Non-Hodgkin 2269Rectal Neoplasms 2192Uterine Cervical Neoplasms 2191Glioblastoma 2016Leukemia, Lymphocytic, Chronic, B-Cell 1992Carcinoma, Renal Cell 1913Squamous Cell Carcinoma of Head and Neck 1880Lymphoma, Follicular 1848Esophageal Neoplasms 1801

Interventions

olaparib 1cabazitaxel 1Prednisone 1Magnetic Resonance Spectroscopy 1Magnetic Resonance Imaging 1Carboplatin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

5 trials
RecentStart dateEnrollment
Prostate Cancer, Hereditary, 7 × Clear all
NCT05384002 2026-06-04

An AI Platform Integrating Imaging Data and Models, Supporting Precision Care Through Prostate Cancer's Continuum

Fondazione del Piemonte per l'Oncologia

Completed
14,000 enrolled
Genitourinary

Prostate Cancer, Hereditary, 7, Prostatic Neoplasms

NCT04052048 2026-04-02

Active Surveillance SNEP Assay Registry Trial for Prostate Cancer

Immunis.AI

Recruiting
2,000 enrolled
Genitourinary

Prostate Cancer, Hereditary, 7

NCT03263650 2026-02-17

Study of Olaparib Maintenance Following Cabazitaxel-Carbo in Men With AVPC

M.D. Anderson Cancer Center

Phase 2 Active not recruiting
96 enrolled
Genitourinary

Prostate Cancer, Hereditary, 7, Prostatic Neoplasms

NCT06662708 2024-10-29

Artificial Intelligence Models for Precision Prediction and Treatment of Prostate Cancer

The First Affiliated Hospital with Nanjing Medical University

Phase NA Not yet recruiting
200 enrolled
Genitourinary

Prostate Cancer, Hereditary, 7, Prostatic Neoplasms

NCT01780701 2017-04-27

MRSI+RRP

OHSU Knight Cancer Institute

Completed
66 enrolled
Genitourinary

Prostate Cancer, Hereditary, 7, Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡